These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Long-term impact of a mass treatment by praziquantel on morbidity due to Schistosoma haematobium in two hyperendemic villages of Niger]. Garba A; Campagne G; Tassie JM; Barkire A; Vera C; Sellin B; Chippaux JP Bull Soc Pathol Exot; 2004 Feb; 97(1):7-11. PubMed ID: 15104149 [TBL] [Abstract][Full Text] [Related]
10. The immunofluorescence antibody test (IFAT) for the diagnosis of schistosomiasis used in a non-endemic area. Tarp B; Black FT; Petersen E Trop Med Int Health; 2000 Mar; 5(3):185-91. PubMed ID: 10747281 [TBL] [Abstract][Full Text] [Related]
11. Schistosomiasis-from immunopathology to vaccines. McManus DP; Bergquist R; Cai P; Ranasinghe S; Tebeje BM; You H Semin Immunopathol; 2020 Jun; 42(3):355-371. PubMed ID: 32076812 [TBL] [Abstract][Full Text] [Related]
12. Schistosomiasis: challenges for control, treatment and drug resistance. Fenwick A; Webster JP Curr Opin Infect Dis; 2006 Dec; 19(6):577-82. PubMed ID: 17075334 [TBL] [Abstract][Full Text] [Related]
13. Refined stratified-worm-burden models that incorporate specific biological features of human and snail hosts provide better estimates of Schistosoma diagnosis, transmission, and control. Gurarie D; King CH; Yoon N; Li E Parasit Vectors; 2016 Aug; 9(1):428. PubMed ID: 27492409 [TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
15. [Effect of comprehensive control project on schistosomiasis in Nanjian county]. Zuo JM; Wu JS; Yang MX; Li D; Jiao D; Lian F; Yang QQ Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Apr; 23(2):113, 120. PubMed ID: 22164604 [TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of the impact of partially protective anti-schistosomiasis vaccines. Alsallaq RA; Gurarie D; Ndeffo Mbah M; Galvani A; King C PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005544. PubMed ID: 28410369 [TBL] [Abstract][Full Text] [Related]
17. Cost of interventions to control schistosomiasis: A systematic review of the literature. Salari P; Fürst T; Knopp S; Utzinger J; Tediosi F PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008098. PubMed ID: 32226008 [TBL] [Abstract][Full Text] [Related]
18. Impact of Annual Praziquantel Treatment on Urogenital Schistosomiasis in a Seasonal Transmission Focus in Central Senegal. Senghor B; Diaw OT; Doucoure S; Seye M; Diallo A; Talla I; Bâ CT; Sokhna C PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004557. PubMed ID: 27015646 [TBL] [Abstract][Full Text] [Related]
20. Developing a comprehensive response for treatment of children under 6 years of age with schistosomiasis: research and development of a pediatric formulation of praziquantel. Reinhard-Rupp J; Klohe K Infect Dis Poverty; 2017 Aug; 6(1):122. PubMed ID: 28768535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]